{
  "scenario_id": "healthcare_genomics_population_screening_program_implementation_2025",
  "context": "National health system, 500000 employees, evaluating population-wide genomic screening for preventive care",
  "stakeholders": {
    "requester": "Chief Medical Officer",
    "approvers": ["Minister of Health", "National Health Board", "Finance Minister"],
    "influencers": ["Patient Advocacy Groups", "Medical Professional Societies", "Privacy Commissioners", "Insurance Providers"]
  },
  "request": {
    "amount": "€500M",
    "purpose": "Implement national genomic screening program for preventive disease detection",
    "urgency": "medium",
    "justification": "Genomic screening offers 30% reduction in disease incidence and €2B annual healthcare cost savings through prevention"
  },
  "decision_process": [
    {
      "stage": "clinical_evidence_review",
      "duration": "8 weeks",
      "activities": ["Clinical trial analysis", "Cost-effectiveness studies", "International program evaluation"],
      "outcome": "Strong clinical evidence supporting preventive screening benefits"
    },
    {
      "stage": "ethical_legal_assessment",
      "duration": "6 weeks",
      "activities": ["Privacy impact assessment", "Consent framework development", "Ethical review"],
      "outcome": "Comprehensive privacy and ethical framework with public consultation"
    },
    {
      "stage": "implementation_feasibility",
      "duration": "10 weeks",
      "activities": ["Infrastructure assessment", "Workforce planning", "Technology evaluation"],
      "outcome": "Feasible implementation with phased rollout strategy"
    },
    {
      "stage": "public_engagement",
      "duration": "8 weeks",
      "activities": ["Public consultation", "Stakeholder workshops", "Communication campaign"],
      "outcome": "Strong public support with 70% approval rating"
    },
    {
      "stage": "government_approval",
      "duration": "4 weeks",
      "activities": ["Cabinet review", "Parliamentary approval", "Funding allocation"],
      "outcome": "Approved with enhanced privacy protections and evaluation framework"
    }
  ],
  "business_impact": {
    "health_outcomes": "30% reduction in preventable diseases and improved population health metrics",
    "economic_benefits": "€2B annual savings in healthcare costs through early intervention",
    "preventive_focus": "Shift from treatment to prevention with long-term sustainability benefits",
    "innovation_ecosystem": "Development of domestic genomics industry and research capabilities",
    "risk_factors": ["Privacy concerns", "Data security risks", "Clinical utility validation", "Public acceptance", "Cost overruns"]
  },
  "decision_outcome": "Approved €500M program with 5-year implementation timeline; includes voluntary opt-in model, comprehensive privacy framework, and independent evaluation committee to monitor clinical outcomes and cost effectiveness"
}